Fjarde Ap Fonden Repligen Corp Transaction History
Fjarde Ap Fonden
- $9.04 Billion
- Q1 2024
A detailed history of Fjarde Ap Fonden transactions in Repligen Corp stock. As of the latest transaction made, Fjarde Ap Fonden holds 12,500 shares of RGEN stock, worth $1.74 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
12,500
Previous 11,800
5.93%
Holding current value
$1.74 Million
Previous $2.12 Million
8.34%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
494Shares Held
53.8MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.06 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$707 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$643 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$242 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$198 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.74B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....